Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Ebihara

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Biochemical and Biophysical Research Communications|January 22, 1998
Identification of the human leptin 5'-flanking sequences involved in the trophoblast-specific transcriptionK Ebihara, Y Ogawa, N Isse, et al.
Diabetologia|January 27, 2009
Beneficial effects of leptin on glycaemic and lipid control in a mouse model of type 2 diabetes with increased adiposity induced by streptozotocin and a high-fat dietT Kusakabe, H Tanioka, K Ebihara, et al.
Molecular and Cellular Biology|July 1, 1996
Intron retention generates a novel isoform of the murine vitamin D receptor that acts in a dominant negative way on the vitamin D signaling pathwayK Ebihara, Y Masuhiro, T Kitamoto, et al.
FEBS Letters|December 31, 1997
Kidney-specific expression of a novel mouse organic cation transporter-like proteinK Mori, Y Ogawa, K Ebihara, et al.
Journal of Nutritional Science and Vitaminology|January 1, 1980
Quantitative analysis of cholesterol in foods by gas-liquid chromatographyT Kaneda, A Nakajima, K Fujimoto, et al.
Diabetes|July 30, 1999
Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal yellow agouti mutation: usefulness of leptin for the treatment of obesity-associated diabetesH Masuzaki, Y Ogawa, M Aizawa-Abe, et al.
Diabetes|March 29, 2001
Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathwayM Shintani, Y Ogawa, K Ebihara, et al.
The Journal of Clinical Investigation|May 3, 2000
Pathophysiological role of leptin in obesity-related hypertensionM Aizawa-Abe, Y Ogawa, H Masuzaki, et al.
American Journal of Physiology. Endocrinology and Metabolism|February 13, 2001
Decreased triglyceride-rich lipoproteins in transgenic skinny mice overexpressing leptinN Matsuoka, Y Ogawa, H Masuzaki, et al.
Diabetes|October 8, 1999
Involvement of agouti-related protein, an endogenous antagonist of hypothalamic melanocortin receptor, in leptin actionK Ebihara, Y Ogawa, G Katsuura, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Biochemical and Biophysical Research Communications|January 22, 1998
Identification of the human leptin 5'-flanking sequences involved in the trophoblast-specific transcriptionK Ebihara, Y Ogawa, N Isse, et al.
Diabetologia|January 27, 2009
Beneficial effects of leptin on glycaemic and lipid control in a mouse model of type 2 diabetes with increased adiposity induced by streptozotocin and a high-fat dietT Kusakabe, H Tanioka, K Ebihara, et al.
Molecular and Cellular Biology|July 1, 1996
Intron retention generates a novel isoform of the murine vitamin D receptor that acts in a dominant negative way on the vitamin D signaling pathwayK Ebihara, Y Masuhiro, T Kitamoto, et al.
FEBS Letters|December 31, 1997
Kidney-specific expression of a novel mouse organic cation transporter-like proteinK Mori, Y Ogawa, K Ebihara, et al.
Journal of Nutritional Science and Vitaminology|January 1, 1980
Quantitative analysis of cholesterol in foods by gas-liquid chromatographyT Kaneda, A Nakajima, K Fujimoto, et al.
Diabetes|July 30, 1999
Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal yellow agouti mutation: usefulness of leptin for the treatment of obesity-associated diabetesH Masuzaki, Y Ogawa, M Aizawa-Abe, et al.
Diabetes|March 29, 2001
Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathwayM Shintani, Y Ogawa, K Ebihara, et al.
The Journal of Clinical Investigation|May 3, 2000
Pathophysiological role of leptin in obesity-related hypertensionM Aizawa-Abe, Y Ogawa, H Masuzaki, et al.
American Journal of Physiology. Endocrinology and Metabolism|February 13, 2001
Decreased triglyceride-rich lipoproteins in transgenic skinny mice overexpressing leptinN Matsuoka, Y Ogawa, H Masuzaki, et al.
Diabetes|October 8, 1999
Involvement of agouti-related protein, an endogenous antagonist of hypothalamic melanocortin receptor, in leptin actionK Ebihara, Y Ogawa, G Katsuura, et al.
Pageof 9